Kefah Mokbel: Does Turning 70 Change the Case for Radiotherapy After Breast-Conserving Surgery?
Kefah Mokbel/ LinkedIn

Kefah Mokbel: Does Turning 70 Change the Case for Radiotherapy After Breast-Conserving Surgery?

Kefah Mokbel, Professor of Medicine (Honorary) at Cardiff University School of Medicine, shared on LinkedIn:

“Does turning 70 change the case for radiotherapy after breast-conserving surgery?

A new SEER study by Sun and colleagues gives us reason to be cautious about using age alone to recommend omission.

The authors studied 8,934 women aged 70 or older with hormone receptor-positive, T1-2N0M0 breast cancer who underwent breast-conserving surgery.

Among 2,591 propensity-matched pairs, five-year overall survival was 88.8% with radiotherapy versus 82.3% without it. The corresponding cumulative incidence of breast cancer death was 1.33% versus 2.80%. Sun et al., ⁠International Journal of Women’s Health⁠.

How much of that survival difference can we attribute to radiotherapy?

Of 718 deaths in the matched cohort, 598 were confirmed to be from other causes.

SEER lacked data on frailty, comorbidities and endocrine therapy adherence. Healthier women may have been more likely to receive radiotherapy, and propensity matching cannot account for those unmeasured differences.

The randomised PRIME II trial gives us a firmer estimate of what radiotherapy achieves in carefully selected older women receiving endocrine therapy. At 10 years, local recurrence was 9.5% without radiotherapy versus 0.9% with it, while overall survival was approximately 81% in both groups.

In my practice, I would offer omission as an option to a woman who meets the trial criteria. I would also explain what radiotherapy achieved for women like her: about nine fewer local recurrences per 100 women over 10 years.

Her tumour features, life expectancy, likelihood of continuing endocrine therapy and the importance she places on avoiding another breast cancer operation should guide that shared decision.”

Title: Adjuvant Radiotherapy and Survival After Breast-Conserving Surgery in Women Aged ≥70 Years with Hormone Receptor-Positive T1-2N0M0 Breast Cancer: A Propensity Score-Matched SEER Study

Authors: Linyue Sun, Xinian Jiang, Ziyu Chen, Peilin Chen, Yuanzhi Li, Fenghua Zhang

Read the article

You can also read:

Felipe Couñago: Encouraging Long-Term Results of 5-Fraction Breast Radiotherapy.

Ioannis Zerdes: The Emerging Role of Tumour-Infiltrating Lymphocytes in Breast Radiotherapy.